Search Results - alaina+howe

2 Results Sort By:
Non-intuitive combination of drug delivery carriers of the same drug for synergistic growth delay of solid tumors
Non-intuitive combination of drug delivery carriers of the same drug for synergistic growth delay of solid tumorsJHU Ref #: C15411 Unmet NeedCancer is the second leading cause of death in the United States, with an estimated 1.8 million cases having been diagnosed and 606,520 people having succumbed to the disease in 2020. The most common cancer diagnosis...
Published: 3/13/2026   |   Inventor(s): Stavroula Sofou, Alaina Howe
Keywords(s): Breast Cancer, Cancers, Disease Indication, Drug Delivery Vehicle, Nanoparticles, Therapeutic Matter, Therapeutics
Category(s): Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Clinical and Disease Specializations > Oncology
Adhesive/adsorption switch on nanoparticles to increase tumor uptake and delay tumor clearance
Unmet NeedEffective drug delivery to solid tumors remains challenging. Outcome failure rates can reach 90% for current therapeutic approaches for solid tumors. The use of nanoparticles for the delivery of therapeutic agents can enhance the safety, pharmacokinetic profile, and bioavailability of administered drugs, leading to improved therapeutic tolerance...
Published: 3/13/2026   |   Inventor(s): Stavroula Sofou, Sarah Stras, Alaina Howe, Aprameya Ganesh Prasad, Dominick Salerno
Keywords(s): Cancers, Disease Indication, Drug Delivery Vehicle, Drug Delivery Vehicle Synthesis Method, Nanoparticles, Therapeutic Matter, Therapeutics
Category(s): Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum